SUPRIYA LIFESCIENCE
Back to Balance Sheet
|
SUPRIYA LIFESCIENCE Last 5 Year Total Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹1,117 Cr | ₹924 Cr | ₹820 Cr | ₹735 Cr | ₹445 Cr |
What is the latest Total Liabilities ratio of SUPRIYA LIFESCIENCE ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹1,117 Cr |
| Mar2024 | ₹924 Cr |
| Mar2023 | ₹820 Cr |
| Mar2022 | ₹735 Cr |
| Mar2021 | ₹445 Cr |
How is Total Liabilities of SUPRIYA LIFESCIENCE Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,117 Cr | 20.94 | |
| Mar2024 | ₹924 Cr | 12.63 | |
| Mar2023 | ₹820 Cr | 11.64 | |
| Mar2022 | ₹735 Cr | 64.94 | |
| Mar2021 | ₹445 Cr | - | |
Compare Total Liabilities of peers of SUPRIYA LIFESCIENCE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUPRIYA LIFESCIENCE | ₹6,976.9 Cr | 2.6% | -12.9% | 24.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹477,312.0 Cr | 0.8% | 6.3% | 18.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹213,879.0 Cr | 8.6% | 20.7% | 18.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹194,094.0 Cr | 1.7% | 9.4% | 38.5% | Stock Analytics | |
| CIPLA | ₹118,992.0 Cr | 4.5% | 1.2% | -1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,787.4 Cr | -0.3% | -14.8% | -9.5% | Stock Analytics | |
SUPRIYA LIFESCIENCE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUPRIYA LIFESCIENCE | 2.6% |
-12.9% |
24.5% |
| SENSEX | 2.7% |
1.5% |
-5.6% |
You may also like the below Video Courses